1. Home
  2. PSTV vs KLTO Comparison

PSTV vs KLTO Comparison

Compare PSTV & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • KLTO
  • Stock Information
  • Founded
  • PSTV 1996
  • KLTO 2019
  • Country
  • PSTV United States
  • KLTO United States
  • Employees
  • PSTV N/A
  • KLTO N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • KLTO
  • Sector
  • PSTV Health Care
  • KLTO
  • Exchange
  • PSTV Nasdaq
  • KLTO NYSE
  • Market Cap
  • PSTV 7.9M
  • KLTO 7.2M
  • IPO Year
  • PSTV N/A
  • KLTO N/A
  • Fundamental
  • Price
  • PSTV $1.18
  • KLTO $0.37
  • Analyst Decision
  • PSTV Strong Buy
  • KLTO
  • Analyst Count
  • PSTV 2
  • KLTO 0
  • Target Price
  • PSTV $14.00
  • KLTO N/A
  • AVG Volume (30 Days)
  • PSTV 111.7K
  • KLTO 160.2K
  • Earning Date
  • PSTV 11-14-2024
  • KLTO 11-19-2024
  • Dividend Yield
  • PSTV N/A
  • KLTO N/A
  • EPS Growth
  • PSTV N/A
  • KLTO N/A
  • EPS
  • PSTV N/A
  • KLTO N/A
  • Revenue
  • PSTV $5,725,000.00
  • KLTO N/A
  • Revenue This Year
  • PSTV $11.13
  • KLTO N/A
  • Revenue Next Year
  • PSTV N/A
  • KLTO N/A
  • P/E Ratio
  • PSTV N/A
  • KLTO N/A
  • Revenue Growth
  • PSTV 52.63
  • KLTO N/A
  • 52 Week Low
  • PSTV $1.15
  • KLTO $0.26
  • 52 Week High
  • PSTV $2.67
  • KLTO $13.10
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 40.01
  • KLTO N/A
  • Support Level
  • PSTV $1.16
  • KLTO N/A
  • Resistance Level
  • PSTV $1.42
  • KLTO N/A
  • Average True Range (ATR)
  • PSTV 0.11
  • KLTO 0.00
  • MACD
  • PSTV -0.01
  • KLTO 0.00
  • Stochastic Oscillator
  • PSTV 6.06
  • KLTO 0.00

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.

Share on Social Networks: